A SOLUBLE PROTEASE IDENTIFIED FROM RAT-KIDNEY DEGRADES ENDOTHELIN-1 BUT NOT PROENDOTHELIN-1

被引:16
作者
DENG, Y [1 ]
MARTIN, LL [1 ]
DELGRANDE, D [1 ]
JENG, AY [1 ]
机构
[1] CIBA GEIGY CORP,DIV PHARMACEUT,RES DEPT,556 MORRIS AVE,SUMMIT,NJ 07901
关键词
D O I
10.1093/oxfordjournals.jbchem.a123858
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endothelin-1 (ET-1) is a potent peptidic vasoconstrictor. This peptide has been shown to be cleared rapidly by the kidney. The purpose of the present study was to assess the involvement of renal proteolytic enzymes in the clearance/degradation of ET- 1. Incubation of ET-1 with the cytosolic fraction of rat kidney homogenate resulted in a decrease of contractile activity on rabbit aortic rings when compared to the untreated ET-1. This cytosolic fraction was chromatographed by anion-exchange and concanavalin A columns. The partially purified enzyme cleaved off the C-terminal tryptophan of ET-1 rapidly, resulting in a peptide which is three orders of magnitude weaker in potency than ET-1 in causing smooth muscle contraction. In contrast, proendothelin-1 was not degraded by this endothelin degradation enzyme (EDE). The effects of EDE on other vasoactive peptides were also examined. The C-terminal tyrosine of atrial natriuretic peptide was cleaved by EDE, but the biological activity of the resulting peptide was not significantly changed. Angiotensin II was not a substrate for EDE. The EDE was shown to be different from both carboxypeptidases A and B based on the HPLC analysis of the degradation products of ET-1 produced by these enzymes. In addition, these enzymes displayed different sensitivities toward a carboxypeptidase inhibitor from potato tuber. These results suggest that this previously unidentified enzyme inactivates ET-1 effectively and that it may play a role in modulating the levels of ET-1 in the kidney.
引用
收藏
页码:168 / 172
页数:5
相关论文
共 28 条
[1]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[2]   ENDOTHELIN - A NEW FAMILY OF ENDOTHELIUM-DERIVED PEPTIDES WITH WIDESPREAD BIOLOGICAL PROPERTIES [J].
DEGOUVILLE, ACL ;
LIPPTON, HL ;
CAVERO, I ;
SUMMER, WR ;
HYMAN, AL .
LIFE SCIENCES, 1989, 45 (17) :1499-1513
[3]   IDENTIFICATION AND PARTIAL-PURIFICATION OF A THIOL ENDOTHELIN-CONVERTING ENZYME FROM PORCINE AORTIC ENDOTHELIAL-CELLS [J].
DENG, YL ;
SAVAGE, P ;
SHETTY, SS ;
MARTIN, LL ;
JENG, AY .
JOURNAL OF BIOCHEMISTRY, 1992, 111 (03) :346-351
[4]   POST-TRANSLATIONAL PROTEOLYSIS IN POLYPEPTIDE HORMONE BIOSYNTHESIS [J].
DOCHERTY, K ;
STEINER, DF .
ANNUAL REVIEW OF PHYSIOLOGY, 1982, 44 :625-638
[5]   SECRETORY MECHANISM OF IMMUNOREACTIVE ENDOTHELIN IN CULTURED BOVINE ENDOTHELIAL-CELLS [J].
EMORI, T ;
HIRATA, Y ;
OHTA, K ;
SHICHIRI, M ;
MARUMO, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 160 (01) :93-100
[6]   NEUTRAL ENDOPEPTIDASE 24.11 (ENKEPHALINASE) AND RELATED REGULATORS OF PEPTIDE-HORMONES [J].
ERDOS, EG ;
SKIDGEL, RA .
FASEB JOURNAL, 1989, 3 (02) :145-151
[7]   INHIBITION OF BIOLOGICAL ACTIONS OF BIG ENDOTHELIN-1 BY PHOSPHORAMIDON [J].
FUKURODA, T ;
NOGUCHI, K ;
TSUCHIDA, S ;
NISHIKIBE, M ;
IKEMOTO, F ;
OKADA, K ;
YANO, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 172 (02) :390-395
[8]   CARDIOVASCULAR, RENAL, AND ENDOCRINE RESPONSES TO INTRAVENOUS ENDOTHELIN IN CONSCIOUS DOGS [J].
GOETZ, KL ;
WANG, BC ;
MADWED, JB ;
ZHU, JL ;
LEADLEY, RJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (06) :R1064-R1068
[9]  
GOODMAN FR, 1971, J PHARMACOL EXP THER, V177, P415
[10]  
HEMSEN A, ACTA PHYSL SCAND, P3